Clinical impact of estradiol/testosterone ratio in patients with acute ischemic stroke - PubMed (original) (raw)

doi: 10.1186/s12883-021-02116-9.

In Woo Ryoo # 2, Jun Yeong Hong 2, Kyung-Yul Lee 3, Hyo Suk Nam 3, Won Chan Kim 1, Seung-Hun Oh 1, Jaeku Kang 4, Hoi Young Lee 4, Sang-Jun Na 2, Ji Hoe Heo 3, Kee Ook Lee 5 6

Affiliations

Clinical impact of estradiol/testosterone ratio in patients with acute ischemic stroke

Jung-Won Choi et al. BMC Neurol. 2021.

Abstract

Background: Sex hormones may be associated with a higher incidence of ischemic stroke or stroke-related events. In observational studies, lower testosterone concentrations are associated with infirmity, vascular disease, and adverse cardiovascular risk factors. Currently, female sexual hormones are considered neuroprotective agents. The purpose of this study was to assess the role of sex hormones and the ratio of estradiol/testosterone (E/T) in patients with acute ischemic stroke (AIS).

Methods: Between January 2011 and December 2016, 146 male patients with AIS and 152 age- and sex-matched control subjects were included in this study. Sex hormones, including estradiol, progesterone, and testosterone, were evaluated in the AIS patient and control groups. We analyzed the clinical and physiological levels of sex hormones and hormone ratios in these patients.

Results: The E/T ratio was significantly elevated among patients in the stroke group compared to those in the control group (P = 0.001). Categorization of data into tertiles revealed that patients with the highest E/T ratio were more likely to have AIS [odds ratio (OR) 3.084; 95% Confidence interval (CI): 1.616-5.886; P < 0.001) compared with those in the first tertile. The E/T ratio was also an independent unfavorable outcome predictor with an adjusted OR of 1.167 (95% CI: 1.053-1.294; P = 0.003).

Conclusions: These findings support the hypothesis that increased estradiol and reduced testosterone levels are associated with AIS in men.

Keywords: Acute ischemic stroke; Functional outcome; Men; Sex hormones; estradiol/testosterone ratio.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1

Fig. 1

Boxplot of the estradiol/testosterone (E/T) ratio according to early functional neurological outcomes

References

    1. McEwen BS, Milner TA. Understanding the broad influence of sex hormones and sex differences in the brain. J Neurosci Res. 2017;95(1–2):24–39. doi: 10.1002/jnr.23809. - DOI - PMC - PubMed
    1. Kim T, Chelluboina B, Chokkalla AK, Vemuganti R. Age and sex differences in the pathophysiology of acute CNS injury. Neurochem Int. 2019;127:22–8. doi: 10.1016/j.neuint.2019.01.0122019.01.012. - DOI - PMC - PubMed
    1. Spychala MS, Honarpisheh P, McCullough LD. Sex differences in neuroinflammation and neuroprotection in ischemic stroke. J Neurosci Res. 2017;95(1–2):462–71. doi: 10.1002/jnr.23962. - DOI - PMC - PubMed
    1. Faulkner JL, Belin de Chantemele EJ. Sex hormones, aging and cardiometabolic syndrome. Biol Sex Differ. 2019;10 1:30. doi: 10.1186/s13293-019-0246-6. - DOI - PMC - PubMed
    1. Castelo-Branco C, Soveral I. The immune system and aging: a review. Gynecol Endocrinol. 2014;30 1:16–22. doi: 10.3109/09513590.2013.8525312013.852531. - DOI - PubMed

MeSH terms

Substances

LinkOut - more resources